The anticonvulsant and antioxidant effects of berberine in kainate-induced temporal lobe epilepsy in rats

Basic and Clinical Neuroscience

Volumn 5, Issue 2, 2014, Pages 124-130

  Mojarad, Tourandokht Baluchnejad ^a   Roghani, Mehrdad ^b  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHED UNIVERSITY   (Iran)

Author keywords

Berberine; Hippocampus; Kainic acid; Oxidative stress; Rat; Seizure

Indexed keywords

BERBERINE; KAINIC ACID; LIPID; NITRITE; SUPEROXIDE DISMUTASE;

ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BIOCHEMISTRY; CHEMICAL PARAMETERS; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; ENZYME ACTIVITY; EPILEPTIC STATE; INCIDENCE; LIPID PEROXIDATION; MALE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; RAT; RECURRENT DISEASE; SCORING SYSTEM; SEIZURE; TEMPORAL LOBE EPILEPSY; TREATMENT RESPONSE;

EID: 84903180103     PISSN: 2008126X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Ashraff, M.R., Shams, S., Nouri, M., Mohseni, M., Shabanian, R., & Yekaninejad, M.S., et al. (2007). A probable causative factor for an old problem: selenium and glutathione peroxidase appear to play important roles in epilepsy pathogenesis. Epilepsia, 48, 1750-1755.
2. Baluchnejadmojarad, T., & Roghani, M. (2011). Chronic epigallocatechin-3-gallate ameliorates learning and memory deffcits in diabetic rats via modulation of nitric oxide and oxidative stress. Behavioral Brain Research, 224, 305-310.
3. Bhutada, P., Mundhada, Y., Bansod, K., Tawari, S., Patil, S., & Dixit, P., et al. (2011). Protection of cholinergic and antioxidant system contributes to the effect of berberine ameliorating memory dysfunction in rat model of streptozotocin-induced diabetes. Behavioral Brain Research, 220, 30-41.
4. Bradford, M. M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry, 72, 248-254.
5. Carrasco, J., Penkowa, M., Hadberg, H., Molinero, A., & Hidalgo, J. (2000). Enhanced seizures and hippocampal neurodegeneration following kainic acid-induced seizures in metallothionein-I + Ildeficient mice. European Journal Neuroscience, 12(7), 2311-22.
6. Coyle, J.T., & Puttfarcken, P. (1993). Oxidative stress, glutamate, and neurodegenerative disorders. Science, 262, 689-695.
7. Cui, H., Matsumoto, K., Murakami, Y., Hori, H., Zhao, Q., & Obi, R. (2009). Berberine Exerts Neuroprotective Actions against in Vitro Ischemia-Induced Neuronal Cell Damage in Organotypic Hippocampal Slice Cultures: Involvement of B-Cell Lymphoma 2 Phosphorylation Suppression. Biological & pharmaceutical bulletin, 32, 79-85.
8. De Sarro, G., Di Paola, E.D., De Sarro, A ., & Vidal, M.J. (1991). Role of nitric oxide in the genesis of excitatory amino acid-induced seizures from the deep prepiriform cortex. Fundamental and Clinical Pharmacology, 5, 503-511.
9. De Sarro, G., Di Paola, E.D., De Sarro, A ., & Vidal, M.J. (1993). L-arginine potentiates excitatory amino acid-induced seizures elicited in the deep prepiriform cortex. European Journal of Pharmacology, 230(2), 151-158.
10. Durairajan, S.S., Liu, L.F., Lu, J.H., Chen, L.L., Yuan, Q., & Chung, S.K., et al. (2012). Berberine ameliorates beta-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model. Neurobiology of Aging, 33, 2903-2919.
11. Floreani, M., Skaper, S. D., Facci, L., Lipartiti, M., & Giusti, P. (1997). Melatonin maintains glutathione homeostasis in kainic acid-exposed rat brain tissues. FASEB Journal, 11(14), 1309-15.
12. Frantseva, M.V., Velazquez, J.L., Hwang, P.A., & Carlen, P.L. (2000). Free radical production correlates with cell death in an in vitro model of epilepsy. European Journal of Neuro Science, 12, 1431-1439.
13. Hong, Y.J., Kim, N., Lee, K., Hee Sonn, C., Eun Lee, J., & Tae Kim, S., et al. (2012). Korean red ginseng (Panax ginseng) ameliorates type 1 diabetes and restores immune cell compartments. Journal of Ethnopharmacology, 144(2), 225-33.
14. Hu, J., Chai, Y., Wang, Y., Kheir, M.M., Li, H., & Yuan, Z., et al. (2012). PI3K p55y promoter activity enhancement is involved in the anti-apoptotic effect of berberine against cerebral ischemia-reperfusion. European Journal of Pharmacology, 674(2-3), 132-42.
15. Imanshahidi, M., & Hosseinzadeh, H. (2008). Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine. Phytotherapy Research, 22, 999-1012.
16. Jokeit, H., & Schacher, M. (2004). Neuropsychological aspects of type of epilepsy and etiological factors in adults. Epilepsy Behavior, 5 Suppl 1, S14 20.
17. Kato, N., Sato, S., & Yokoyama, H. (2005). Sequential changes of nitric oxide levels in the temporal lobes of kainic acid-treated mice following application of nitric oxide synthase inhibitors and phenobarbital. Epilepsy Research, 65, 81-91.
18. Katzung, B.G. (2004). Basic and Clinical Pharmacology. (9th ed.) Boston, London, Toronto: McGraw-Hill Inc.
19. Kim, E.J., Won, R., Sohn, J.H., Chung, M.A., Nam, T.S., & Lee, H.J. et al. (2008). Antioxidant effect of ascorbic and dehydroascorbic acids in hippocampal slice culture. Biochemical and biophysical research communications, 366(1), 8-14.
20. Kim, H.C., Jhoo, W.K., Bing, G., Shin, E.J., Wie, M.B., & Kim, W.K., et al. (2000a). Phenidone prevents kainate-induced neurotoxicity via antioxidant mechanisms. Brain Research, 874(1), 15-23.
21. Kim, H.C., Jhoo, W.K., Kim, W.K., Suh, J.H., Shin, E.J., & Kato, K., et al. (2000b). An immunocytochemical study of mitochondrial manganese-superoxide dismutase in the rat hippocampus after kainate administration. Neuroscience Letter, 281(1), 65-8.
22. Kim, H.C., Choi, D.Y., Jhoo, W.K., Lee, D.W., Koo, C.H., & Kim, C. (1997). Aspalatone, a new antiplatelet agent, attenuates the neurotoxicity induced by kainic acid in the rat. Life Science, 61, PL383-PL381.
23. Kohl, B.K., & Dannhardt, G. (2001). The NMDA receptor complex: a promising target for novel antiepileptic strategies. Current Medicinal Chemistry, 8, 1275-89.
24. Kulkarni, S.K., & Dhir, A. (2008). On the mechanism of antidepressant-like action of berberine chloride. European Journal of Pharmacology, 589, 163-172.
25. Kulkarni, S.K., & Dhir, A. (2010). Berberine: a plant alkaloid with therapeutic potential for central nervous system disorders. Phytotherapy Research, 24, 317-324.
26. Kulkarni, S.K., & Dhir, A. (2007). Possible involvement of L-argininenitric oxide (NO)-cyclic guanosine monophosphate (cGMP) signaling pathway in the antidepressant activity of berberine chloride. European Journal of Pharmacology, 569(1-2), 77-83.
27. Lehtimäki, KA., Peltola, J., Koskikallio, E., Keränen, T., & Honkaniemi, J. (2003). Expression of cytokines and cytokine receptors in the rat brain after kainic acid-induced seizures. Brain research Molecular brain research , 110(2), 253-60.
28. Lim, J., Kim, H., Choi,Y.S., Kwon, H., Shin, K.S., & Joung, I., et al. (2008). Neuroprotective effects of berberine in neurodegeneration model rats induced by ibotenic acid. Animal Cells and Systems, 12, 203-209.
29. Ma, X., Jiang, Y., Wu, A., Chen, X., Pi, R., & Liu, M. et al. (2010). Berberine attenuates experimental autoimmune encephalomyelitis in C57 BL/6 mice. PLoS One, 5, e13489.
30. Marangoz, C., Ayyildiz, M., & Agar, E. (1994). Evidence that sodium nitroprusside possesses anticonvulsant effects mediated through nitric oxide. Neuro Report, 5, 2454-2456.
31. Migliore, L., Fontana, I., Colognato, R., Coppede, F., Siciliano, G., & Murri, L. (2005). Searching for the role and the most suitable biomarkers of oxidative stress in Alzheimer's disease and in other neurodegenerative diseases. Neurobiology Aging, 26, 587-595.
32. Mülsch, A., Busse, R., Mordvintcev, P.I., Vanin, A.F., Nielsen, E.O., Scheel-Krüger, J., et al. (1994). Nitric oxide promotes seizure activity in kainate-treated rats. Neuro Report, 5, 2325-2328.
33. Peng, W.H., Hsieh, M.T., & Wu, C.R. (1997). Effect of long-term administration of berberine on scopolamine-induced amnesia in rats. Japanese journal of pharmacology, 74, 261-266.
34. Perry, G., Nunomura, A., Hirai, K., Zhu, X., Perez, M., Avila, J., et al. (2002). Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative disease? Free Radic. Biology and Medicine, 33, 1475-1479.
35. Racine, R., Okujava, V., & Chipashvili, S. (1972). Modification of seizure activity by electrical stimulation. 3. Mechanisms. Electroencephalography and clinical neurophysiology, 32, 295-299.
36. Roghani, M., & Baluchnejadmojarad, T. (2009). Chronic epigallocatechin-gallate improves aortic reactivity of diabetic rats: Underlying mechanisms. Vascular Pharmacology, 51(2-3), 84-89.
37. Saija, A., Princi, P., Pisani, A., Lanza, M., Scalese, M., & Aramnejad, E., et al. (1994). Protective effect of glutathione on kainic acid-induced neuropathological changes in the rat brain. General Pharmacology, 25, 97-102.
38. Sharma, A.K., Reams, R.Y., Jordan, W.H., Miller, M.A., Thacker, H.L., & Snyder, P.W. (2007). Mesial temporal lobe epilepsy: pathogenesis, induced rodent models and lesions. Toxicologic Pathology, 35, 984-999.
39. Sherin, A., Anu, J., Peeyush, K.T., Smijin, S., Anitha, M., & Roshni, B.T., et al. (2012). Cholinergic and GABAergic receptor functional deficit in the hippocampus of insulin-induced hypoglycemic and streptozotocin-induced diabetic rats. Neuroscience, 202, 69-76.
40. Shin, E.J., Ko, K.H., Kim, W.K., Chae, J.S., Yen, T.P., & Kim, H.J., et al. (2008). Role of glutathione peroxidase in the ontogeny of hippocampal oxidative stress and kainate seizure sensitivity in the genetically epilepsyprone rats. Neurochemistry international, 52, 1134-1147.
41. Sloviter, R.S. (2005). The neurobiology of temporal lobe epilepsy: too much information, not enough knowledge. Comptes Rendus Biologies, 328(2), 143-53.
42. Sperk, G. (1994). Kainic acid seizures in the rat. Progress in Neurobiology, 42(1), 1-32.
43. Sumanont, Y., Murakami, Y., Tohda, M., Vajragupta, O., Watanabe, H., & Matsumoto, K. (2006). Prevention of kainic acid-induced changes in nitric oxide level and neuronal cell damage in the rat hippocampus by manganese complexes of curcumin and diacetylcurcumin. Life Science. 78, 1884-1891.
44. Tan, Y., Tang, Q., Hu, B.R., & Xiang, J.Z. (2007). Antioxidant properties of berberine on cultured rabbit corpus cavernosum smooth muscle cells injured by hydrogen peroxide. Acta pharmacologica Sinica, 28, 1914-1918.
45. Tang, L., Reiter, R.J., Li, Z.R., Ortiz, G.G., Yu, B.P., & Garcia, J.J. (1998). Melatonin reduces the increase in 8-hydroxy-deoxy-guanosine levels in the brain and liver of kainic acid-treated rats. Molecular and cellular biochemistry, 178, 299-303.
46. Wang, F., Zhao, G., Cheng, L., Zhou, H.Y., Fu, L.Y., & Yao, W.X. (2004). Effects of berberine on potassium currents in acutely isolated CA1 pyramidal neurons of rat hippocampus. Brain Research, 999, 91-97.
47. Xiao, B., Bi, F.F., Hu, Y.Q., Tian, F.F., Wu, Z.G., & Mujlli, H.M., et al. (2007). Edaravone neuroprotection affected by suppressing the gene expression of the Fas signal pathway following transient focal ischemia in rats. Neurotoxicity Research, 12, 155-162.
48. Yoo, K.Y., Hwang, I.K., Lim, B.O., Kang, T.C., Kim, D.W., & Kim, S.M., et al. (2006). Berberry extract reduces neuronal damage and N-Methyl-D-aspartate receptor 1 immunoreactivity in the gerbil hippocampus after transient forebrain ischemia. Biological and pharmaceutical bulletin, 29, 623-628.
49. Zarch, A.V., Toroudi, H.P., Soleimani, M., Bakhtiarian, A., Katebi, M., & Djahanguiri, B. (2009). Neuroprotective effects of diazoxide and its antagonism by glibenclamide in pyramidal neurons of rat hippocampus subjected to ischemiareperfusion-induced injury. International Journal of Neuro-science, 119, 1346-1361.
50. Zhou, X.Q., Zeng, X.N., Kong, H., & Sun, X.L. (2008). Neuroprotective effects of berberine on stroke models in vitro and in vivo. Neuroscience Letter, 447, 31-36.
51. Zhu, X., Guo, X., Mao, G., Gao, Z., Wang, H., & He, Q., et al. (2013). Hepatoprotection of berberine against hydrogen peroxide-induced apoptosisby upregulation of sirtuin 1. Phytotherapy Research, 27(3), 417-21.